{"id":"https://openalex.org/W7204185491","doi":"https://doi.org/10.1177/20406207261484097","title":"Targeting CD38 in relapsed /refractory T-cell acute lymphoblastic leukemia/lymphoma: A systematic review of daratumumab-based therapy","display_name":"Targeting CD38 in relapsed /refractory T-cell acute lymphoblastic leukemia/lymphoma: A systematic review of daratumumab-based therapy","publication_year":2026,"publication_date":"2026-08-01","ids":{"openalex":"https://openalex.org/W7204185491","doi":"https://doi.org/10.1177/20406207261484097","pmid":"https://pubmed.ncbi.nlm.nih.gov/42661954","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/13519216"},"language":"en","primary_location":{"id":"doi:10.1177/20406207261484097","doi":"https://doi.org/10.1177/20406207261484097","is_oa":true,"landing_page_url":"https://doi.org/10.1177/20406207261484097","pdf_url":null,"source":{"id":"https://openalex.org/S2765068629","display_name":"Therapeutic Advances in Hematology","issn_l":"2040-6207","issn":["2040-6207","2040-6215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Hematology","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1177/20406207261484097","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5087437050","display_name":"Abdulrahman Fadhl Al-Mashdali","orcid":"https://orcid.org/0000-0002-1393-5302","observed_orcids":["https://orcid.org/0000-0002-1393-5302"]},"institutions":[{"id":"https://openalex.org/I4210118835","display_name":"National Center for Cancer Care and Research","ror":"https://ror.org/02d4f9f51","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210118835","https://openalex.org/I49828101"]},{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["QA"],"is_corresponding":true,"raw_author_name":"Abdulrahman F. Al-Mashdali","raw_affiliation_strings":["National Center for Cancer Care and Research, Hamad Medical Corporation"],"raw_orcid":"https://orcid.org/0000-0002-1393-5302","affiliations":[{"raw_affiliation_string":"National Center for Cancer Care and Research, Hamad Medical Corporation","institution_ids":["https://openalex.org/I4210118835","https://openalex.org/I49828101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050485282","display_name":"Mujahid O Abdelraof","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78157869","display_name":"University of Gezira","ror":"https://ror.org/001mf9v16","country_code":"SD","type":"education","lineage":["https://openalex.org/I78157869"]}],"countries":["SD"],"is_corresponding":false,"raw_author_name":"Mujahid O. Abdelraof","raw_affiliation_strings":["Gezira University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gezira University","institution_ids":["https://openalex.org/I78157869"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5148137548","display_name":"Monia Ibrahim","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I78157869","display_name":"University of Gezira","ror":"https://ror.org/001mf9v16","country_code":"SD","type":"education","lineage":["https://openalex.org/I78157869"]}],"countries":["SD"],"is_corresponding":false,"raw_author_name":"Monia Ibrahim","raw_affiliation_strings":["Gezira University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gezira University","institution_ids":["https://openalex.org/I78157869"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061179334","display_name":"Mohammed Abdulgayoom","orcid":"https://orcid.org/0000-0003-0622-8455","observed_orcids":["https://orcid.org/0000-0003-0622-8455"]},"institutions":[{"id":"https://openalex.org/I4210118835","display_name":"National Center for Cancer Care and Research","ror":"https://ror.org/02d4f9f51","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210118835","https://openalex.org/I49828101"]},{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Mohammed Abdulgayoom","raw_affiliation_strings":["National Center for Cancer Care and Research, Hamad Medical Corporation"],"raw_orcid":"https://orcid.org/0000-0003-0622-8455","affiliations":[{"raw_affiliation_string":"National Center for Cancer Care and Research, Hamad Medical Corporation","institution_ids":["https://openalex.org/I4210118835","https://openalex.org/I49828101"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028674967","display_name":"Shehab Fareed Mohamed","orcid":"https://orcid.org/0000-0001-6118-3988","observed_orcids":["https://orcid.org/0000-0001-6118-3988"]},"institutions":[{"id":"https://openalex.org/I4210118835","display_name":"National Center for Cancer Care and Research","ror":"https://ror.org/02d4f9f51","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210118835","https://openalex.org/I49828101"]},{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Shehab F. Mohamed","raw_affiliation_strings":["National Center for Cancer Care and Research, Hamad Medical Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center for Cancer Care and Research, Hamad Medical Corporation","institution_ids":["https://openalex.org/I4210118835","https://openalex.org/I49828101"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005209836","display_name":"Honar Cherif","orcid":"https://orcid.org/0000-0001-7582-4002","observed_orcids":["https://orcid.org/0000-0001-7582-4002"]},"institutions":[{"id":"https://openalex.org/I4210118835","display_name":"National Center for Cancer Care and Research","ror":"https://ror.org/02d4f9f51","country_code":"QA","type":"healthcare","lineage":["https://openalex.org/I4210118835","https://openalex.org/I49828101"]},{"id":"https://openalex.org/I49828101","display_name":"Hamad Medical Corporation","ror":"https://ror.org/02zwb6n98","country_code":"QA","type":"nonprofit","lineage":["https://openalex.org/I49828101"]}],"countries":["QA"],"is_corresponding":false,"raw_author_name":"Honar Cherif","raw_affiliation_strings":["National Center for Cancer Care and Research, Hamad Medical Corporation"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center for Cancer Care and Research, Hamad Medical Corporation","institution_ids":["https://openalex.org/I4210118835","https://openalex.org/I49828101"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5087437050"],"corresponding_institution_ids":["https://openalex.org/I4210118835","https://openalex.org/I49828101"],"apc_list":{"value":2650,"currency":"USD","value_usd":2650},"apc_paid":{"value":2650,"currency":"USD","value_usd":2650},"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.42342342,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":"20406207261484097","last_page":"20406207261484097"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/daratumumab","display_name":"daratumumab","score":0.9200000166893005},{"id":"https://openalex.org/keywords/cd38","display_name":"CD38","score":0.753000020980835},{"id":"https://openalex.org/keywords/t-lymphoblastic-lymphoma","display_name":"T-cell lymphoblastic lymphoma","score":0.9229999780654907},{"id":"https://openalex.org/keywords/salvage-therapy","display_name":"salvage therapy","score":0.7369999885559082},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.8690000176429749},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9739999771118164},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.8090000152587891},{"id":"https://openalex.org/keywords/infusion-related-reactions","display_name":"infusion reactions","score":0.5329999923706055},{"id":"https://openalex.org/keywords/treatment-safety","display_name":"treatment safety","score":0.5699999928474426}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9692999720573425},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5924000144004822},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.5776000022888184},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5601000189781189},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5371000170707703},{"id":"https://openalex.org/C3018657049","wikidata":"https://www.wikidata.org/wiki/Q1595418","display_name":"Complete remission","level":3,"score":0.5184000134468079},{"id":"https://openalex.org/C3019096185","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Complete response","level":3,"score":0.36149999499320984},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3571000099182129},{"id":"https://openalex.org/C3019894029","wikidata":"https://www.wikidata.org/wiki/Q332823","display_name":"Overall survival","level":2,"score":0.3395000100135803},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.29089999198913574},{"id":"https://openalex.org/C167135981","wikidata":"https://www.wikidata.org/wiki/Q2146302","display_name":"Retrospective cohort study","level":2,"score":0.28380000591278076},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2831999957561493},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.2538999915122986},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.2531999945640564}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1177/20406207261484097","doi":"https://doi.org/10.1177/20406207261484097","is_oa":true,"landing_page_url":"https://doi.org/10.1177/20406207261484097","pdf_url":null,"source":{"id":"https://openalex.org/S2765068629","display_name":"Therapeutic Advances in Hematology","issn_l":"2040-6207","issn":["2040-6207","2040-6215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Hematology","raw_type":"journal-article"},{"id":"pmid:42661954","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42661954","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic advances in hematology","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:13519216","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC13519216/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Ther Adv Hematol","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:6c4724949eda41d0816485d6cbba27d1","doi":null,"is_oa":false,"landing_page_url":"https://doaj.org/article/6c4724949eda41d0816485d6cbba27d1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Therapeutic Advances in Hematology, Vol 17 (2026)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1177/20406207261484097","doi":"https://doi.org/10.1177/20406207261484097","is_oa":true,"landing_page_url":"https://doi.org/10.1177/20406207261484097","pdf_url":null,"source":{"id":"https://openalex.org/S2765068629","display_name":"Therapeutic Advances in Hematology","issn_l":"2040-6207","issn":["2040-6207","2040-6215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320017","host_organization_name":"SAGE Publishing","host_organization_lineage":["https://openalex.org/P4310320017"],"host_organization_lineage_names":["SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Therapeutic Advances in Hematology","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320334468","display_name":"Qatar National Library","ror":"https://ror.org/02jv93662"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":34,"referenced_works":["https://openalex.org/W2012687212","https://openalex.org/W2116475791","https://openalex.org/W2141502099","https://openalex.org/W2331693462","https://openalex.org/W2513243534","https://openalex.org/W2781552270","https://openalex.org/W2785755264","https://openalex.org/W2807333579","https://openalex.org/W2969862977","https://openalex.org/W2971059988","https://openalex.org/W2994180391","https://openalex.org/W3032755334","https://openalex.org/W3034008033","https://openalex.org/W3109824163","https://openalex.org/W3118615836","https://openalex.org/W3136071155","https://openalex.org/W3194647376","https://openalex.org/W4205305674","https://openalex.org/W4206029839","https://openalex.org/W4280563108","https://openalex.org/W4386725772","https://openalex.org/W4387898891","https://openalex.org/W4392169227","https://openalex.org/W4392598142","https://openalex.org/W4395457691","https://openalex.org/W4400963408","https://openalex.org/W4401704812","https://openalex.org/W4404572617","https://openalex.org/W4406778358","https://openalex.org/W4406796901","https://openalex.org/W4409118993","https://openalex.org/W4410126062","https://openalex.org/W4410378989","https://openalex.org/W4411668356"],"related_works":["https://openalex.org/W7204727122","https://openalex.org/W2781552270","https://openalex.org/W4206029839","https://openalex.org/W4400963408","https://openalex.org/W7213312391","https://openalex.org/W3109824163","https://openalex.org/W4411668356","https://openalex.org/W4401704812","https://openalex.org/W4283393911","https://openalex.org/W4402288613"],"abstract_inverted_index":{"Background:":[0],"Relapsed/refractory":[1],"(R/R)":[2],"T-cell":[3],"acute":[4],"lymphoblastic":[5],"leukemia/lymphoma":[6],"(T-ALL/T-LBL)":[7],"has":[8],"poor":[9],"outcomes":[10],"and":[11,20,56,75,100,143,161],"limited":[12],"salvage":[13],"options.":[14],"Objectives:":[15],"To":[16],"evaluate":[17],"the":[18],"efficacy":[19],"safety":[21,57],"of":[22,31],"daratumumab-based":[23,42],"therapy":[24,139],"in":[25,66,72,78,131,147],"R/R":[26],"T-ALL/T-LBL.":[27],"Design:":[28],"Systematic":[29],"review":[30],"observational":[32],"reports.":[33],"Methods:":[34],"Sixteen":[35],"reports":[36,160],"including":[37],"34":[38],"patients":[39,68,115],"treated":[40],"with":[41,84],"regimens":[43],"were":[44,58,123],"reviewed.":[45],"Baseline":[46],"characteristics,":[47],"treatment":[48],"patterns,":[49],"response,":[50],"MRD":[51,86,91],"status,":[52,87],"survival,":[53],"allogeneic":[54,119],"HSCT,":[55],"descriptively":[59],"synthesized.":[60],"Results:":[61],"Complete":[62],"remission":[63,71,142],"was":[64,95,103],"reported":[65,85],"30/34":[67],"(88.2%),":[69],"partial":[70],"2/34":[73,79],"(5.9%),":[74],"no":[76],"response":[77],"(5.9%).":[80],"Among":[81],"complete":[82],"responders":[83],"24/29":[88],"(82.8%)":[89],"achieved":[90],"negativity.":[92],"Median":[93],"PFS":[94],"10":[96,104,132],"months":[97,105],"(range,":[98,106],"0.4-45),":[99],"median":[101],"OS":[102],"1.5-45),":[107],"although":[108],"many":[109],"values":[110],"reflected":[111],"last":[112,126],"follow-up.":[113,127],"Eighteen":[114],"(52.9%)":[116],"proceeded":[117],"to":[118],"HSCT;":[120],"13/18":[121],"(72.2%)":[122],"alive":[124],"at":[125],"Infusion":[128],"reactions":[129],"occurred":[130],"patients,":[133,149],"mostly":[134],"grade":[135],"1-2.":[136],"Conclusion:":[137],"Daratumumab-based":[138],"may":[140],"induce":[141],"facilitate":[144],"HSCT":[145],"bridging":[146],"selected":[148],"but":[150],"findings":[151],"remain":[152],"hypothesis-generating":[153],"because":[154],"evidence":[155],"is":[156],"mainly":[157],"from":[158],"case":[159],"small":[162],"series.":[163]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-26T00:00:00"}